Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Outperform on Pure Storage, Maintains $40 Price Target By Benzinga Newsdesk March 2, 9:00 AM Credit Suisse analyst Shannon Cross reiterates Pure Storage (NYSE:PSTG) with a Outperform and maintains $40 price target. PSTG
Read More 1 minute read Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Neutral on Wendy’s, Maintains $24 Price Target By Benzinga Newsdesk March 2, 8:56 AM Credit Suisse analyst Lauren Silberman reiterates Wendy's (NASDAQ:WEN) with a Neutral and maintains $24 price target. WEN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Coinbase Glb, Maintains $73 Price Target By Benzinga Newsdesk March 2, 7:56 AM Needham analyst John Todaro reiterates Coinbase Glb (NASDAQ:COIN) with a Buy and maintains $73 price target. COIN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Ladenburg Thalmann Reiterates Buy on Rhythm Pharmaceuticals, Maintains $35 Price Target By Benzinga Newsdesk March 2, 7:34 AM Ladenburg Thalmann analyst Michael Higgins reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $35 price target. RYTM
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on CompoSecure, Maintains $15 Price Target By Benzinga Newsdesk March 2, 7:26 AM Needham analyst John Todaro reiterates CompoSecure (NASDAQ:CMPO) with a Buy and maintains $15 price target. CMPO
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on MiMedx Group, Maintains $8 Price Target By Benzinga Newsdesk March 2, 7:09 AM HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target. MDXG
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on G1 Therapeutics, Maintains $11 Price Target By Benzinga Newsdesk March 2, 7:08 AM HC Wainwright & Co. analyst Edward White reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $11 price target. GTHX
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on IVERIC bio, Maintains $35 Price Target By Benzinga Newsdesk March 2, 7:06 AM HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target. ISEE
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Microchip Technology, Maintains $110 Price Target By Benzinga Newsdesk March 2, 6:38 AM Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target. MCHP
Read More 1 minute read Analyst Ratings News Price Target Reiteration Tigress Financial Reiterates Buy on Snap-on, Raises Price Target to $302 By Benzinga Newsdesk March 2, 6:16 AM Tigress Financial analyst Ivan Feinseth reiterates Snap-on (NYSE:SNA) with a Buy and raises the price target from $298 to $302. SNA